Seo Jeong-Woo, Jones Susan M, Hostetter Trisha A, Iliff Jeffrey J, West G Alexander
Neurotrauma Research, Swedish Medical Center, Englewood, Colorado.
Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.
J Neurosci Res. 2016 Feb;94(2):170-8. doi: 10.1002/jnr.23697. Epub 2015 Nov 16.
Methamphetamine is a potent psychostimulant drug of abuse that increases release and blocks reuptake of dopamine, producing intense euphoria, factors that may contribute to its widespread abuse. It also produces severe neurotoxicity resulting from oxidative stress, DNA damage, blood-brain barrier disruption, microgliosis, and mitochondrial dysfunction. Intracerebral hemorrhagic and ischemic stroke have been reported after intravenous and oral abuse of methamphetamine. Several studies have shown that methamphetamine causes vasoconstriction of vessels. This study investigates the effect of methamphetamine on endothelin-1 (ET-1) release in mouse brain endothelial cells by ELISA. ET-1 transcription as well as endothelial nitric oxide synthase (eNOS) activation and transcription were measured following methamphetamine treatment. We also examine the effect of methamphetamine on isolated cerebral arteriolar vessels from C57BL/6 mice. Penetrating middle cerebral arterioles were cannulated at both ends with a micropipette system. Methamphetamine was applied extraluminally, and the vascular response was investigated. Methamphetamine treatment of mouse brain endothelial cells resulted in ET-1 release and a transient increase in ET-1 message. The activity and transcription of eNOS were only slightly enhanced after 24 hr of treatment with methamphetamine. In addition, methamphetamine caused significant vasoconstriction of isolated mouse intracerebral arterioles. The vasoconstrictive effect of methamphetamine was attenuated by coapplication of the endothelin receptor antagonist PD145065. These findings suggest that vasoconstriction induced by methamphetamine is mediated through the endothelin receptor and may involve an endothelin-dependent pathway.
甲基苯丙胺是一种强效的滥用精神刺激药物,它会增加多巴胺的释放并阻断其再摄取,产生强烈的欣快感,这些因素可能导致其广泛滥用。它还会因氧化应激、DNA损伤、血脑屏障破坏、小胶质细胞增生和线粒体功能障碍而产生严重的神经毒性。静脉注射和口服甲基苯丙胺后已有脑出血和缺血性中风的报道。多项研究表明,甲基苯丙胺会导致血管收缩。本研究通过酶联免疫吸附测定法(ELISA)研究甲基苯丙胺对小鼠脑内皮细胞中内皮素-1(ET-1)释放的影响。在甲基苯丙胺处理后,检测ET-1转录以及内皮型一氧化氮合酶(eNOS)的激活和转录情况。我们还研究了甲基苯丙胺对来自C57BL/6小鼠的离体脑小动脉血管的影响。用微量移液器系统在穿透性大脑中动脉小动脉的两端插管。在血管外施加甲基苯丙胺,并研究血管反应。用甲基苯丙胺处理小鼠脑内皮细胞会导致ET-1释放以及ET-1信使的短暂增加。用甲基苯丙胺处理24小时后,eNOS的活性和转录仅略有增强。此外,甲基苯丙胺会导致离体小鼠脑小动脉显著血管收缩。内皮素受体拮抗剂PD145065共同应用可减弱甲基苯丙胺的血管收缩作用。这些发现表明,甲基苯丙胺诱导的血管收缩是通过内皮素受体介导的,可能涉及内皮素依赖性途径。